supported by the National Natural Science Foundation of China,Nos.81941011(to XL),31771053(to HD),31730030(to XL),31971279(to ZY),31900749(to PH),31650001(to XL),31320103903(to XL),31670988(to ZY);the Natural Science Foundation of Beijing,Nos.7222004(to HD);a grant from Ministry of Science and Technology of China,Nos.2017YFC1104002(to ZY),2017YFC1104001(to XL);a grant from Beihang University,No.JKF-YG-22-B001(to FH)。
Attempts have been made to use cell transplantation and biomaterials to promote cell proliferation,differentiation,migration,and survival,as well as angiogenesis,in the context of brain injury.However,whether bioactiv...
supported by the National Natural Science Foundation of China(32071359,11827803,61227902,and U20A20390);National Key Technology R&D Program(2020YFC0122203);International Joint Research Center of Aerospace Biotechnology and Medical Engineering from Ministry of Science and Technology of China;111 Project(B13003);Research Fund for the Doctoral Program of Higher Education of China(20131102130004);Fundamental Research Funds for the Central Universities.
Cell sheet engineering has been proven to be a promising strategy for cardiac remodeling post-myocardial infarction. However, insufficient mechanical strength and low cell retention lead to limited therapeutic efficie...
supported by the National Basic Research Program of China(973 Program,No.2012CB933600);the National Natural Science Foundation of China(Nos.81771964 and 82072051);the Shanghai Municipal Natural Science Foundation(No.15ZR1408500);funded by the Special Project of Clinical Research of Health Industry of Shanghai Municipal Health Commission(No.201940178);the Scientific Research Project of Hongkou District Health Committee of Shanghai(No.2002-17);the Clinical Research Project of Wu Jieping Medical Foundation(No.320.6750.2020-18-2);the Research Project of Shanghai Fourth People’s Hospital(No.sykyqd 00701&00702).
There are several limitations to the application of nanoparticles in the treatment of cancer,including their low drug loading,poor colloidal stability,insufficient tumor penetration,and uncontrolled release of the dru...
financial support from the National Natural Science Foundation of China(Nos.32171345,T2288101,U20A20390,and 11827803);Fok Ying Tung Education Foundation(No.141039);International Joint Research Center of Aerospace Biotechnology and Medical Engineering,Ministry of Science and Technology of China,the 111 Project(No.B13003);the Academic Excellence Foundation of BUAA for PhD Students.
Postoperative adhesion(POA)widely occurs in soft tissues and usually leads to chronic pain,dysfunction of adjacent organs and some acute complications,seriously reducing patients’quality of life and even being life-t...
This study was partially sponsored by the National Natural Science Foundation of China(NSFC)(81761148029,81725009,82030049,82021002,81971641);Ministry of Science and Technology of China(MOST)(2021YFA110004500,2021YFE0108300);Clinical Research Plan of SHDC(SHDC2020CR1038B);Science and Technology Innovation 2030 Major Projects(2022ZD0211600);Swiss National Science Foundation(project nos.185028,188355,and 169876);National Research Foundation of Korea(NRF-2017K2A9A2A10013554).
Alzheimer’s disease(AD)is the main cause of dementia,with its diagnosis and management remaining challenging.Amyloid positron emission tomography(PET)has become increasingly important in medical practice for patients...
financially supported by the Ministry of Science and Technology of China(No.2022YFE0110200);the Natural Science Foundation of Hunan Province of China(No.2021JJ30680);the National Natural Science Foundation of China(Nos.52203198,52025035 and 52103195)。
Combretastatin A4 phosphate(CA4P)is a potent vascular disrupting agent with good water solubility.However,it is only effective at high doses,which decreases clinical applicability.Herein,we designed stable CA4P polyme...